In a humanized mouse model, intravenous administration of human MSCs inhibited pathological T cell infiltration and proinflammatory cytokine production in mouse lung tissue and attenuated bleomycin-induced pulmonary fibrosis, while PD-L1 monoclonal antibody significantly interfered with these therapeutic effects (160). This evidence concerns the gene CD274 and pulmonary fibrosis.